These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1321752)

  • 41. Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).
    Wang J; Mazar A; Quan N; Schneider A; Henkin J
    Eur J Biochem; 1997 Jul; 247(1):256-61. PubMed ID: 9249034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
    Jankun J; Merrick HW; Goldblatt PJ
    J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells.
    Cavallo-Medved D; Mai J; Dosescu J; Sameni M; Sloane BF
    J Cell Sci; 2005 Apr; 118(Pt 7):1493-503. PubMed ID: 15769846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
    Behrendt N; Danø K
    FEBS Lett; 1996 Sep; 393(1):31-6. PubMed ID: 8804418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S; Vrhovec I; Svetic B; Cufer T
    Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.
    Tecimer C; Doering DL; Goldsmith LJ; Meyer JS; Abdulhay G; Wittliff JL
    Gynecol Oncol; 2001 Jan; 80(1):48-55. PubMed ID: 11136569
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
    Tarui T; Akakura N; Majumdar M; Andronicos N; Takagi J; Mazar AP; Bdeir K; Kuo A; Yarovoi SV; Cines DB; Takada Y
    Thromb Haemost; 2006 Mar; 95(3):524-34. PubMed ID: 16525582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung.
    Hattori N; Sisson TH; Xu Y; Desai TJ; Simon RH
    Am J Physiol; 1999 Sep; 277(3):L573-9. PubMed ID: 10484465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urokinase-type plasminogen activator and its receptor in bladder cancer.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 May; 89(10):678-9. PubMed ID: 9168177
    [No Abstract]   [Full Text] [Related]  

  • 53. Localization and significance of urokinase plasminogen activator and its receptor in placental tissue from intrauterine, ectopic and molar pregnancies.
    Floridon C; Nielsen O; Holund B; Sunde L; Westergaard JG; Thomsen SG; Teisner B
    Placenta; 1999 Nov; 20(8):711-21. PubMed ID: 10527826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.
    Pedersen H; Brünner N; Francis D; Osterlind K; Rønne E; Hansen HH; Danø K; Grøndahl-Hansen J
    Cancer Res; 1994 Sep; 54(17):4671-5. PubMed ID: 8062262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma.
    Dubuisson L; Monvoisin A; Nielsen BS; Le Bail B; Bioulac-Sage P; Rosenbaum J
    J Pathol; 2000 Feb; 190(2):190-5. PubMed ID: 10657018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
    Conese M; Blasi F
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
    Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S
    Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.
    Albo D; Rothman VL; Roberts DD; Tuszynski GP
    Br J Cancer; 2000 Aug; 83(3):298-306. PubMed ID: 10917542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer. Proteases--invasion and more.
    Edwards DR; Murphy G
    Nature; 1998 Aug; 394(6693):527-8. PubMed ID: 9707109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.